Your browser doesn't support javascript.
loading
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I-conceptual challenges.
Rutella, Sergio; Cannarile, Michael A; Gnjatic, Sacha; Gomes, Bruno; Guinney, Justin; Karanikas, Vaios; Karkada, Mohan; Kirkwood, John M; Kotlan, Beatrix; Masucci, Giuseppe V; Meeusen, Els; Monette, Anne; Naing, Aung; Thorsson, Vésteinn; Tschernia, Nicholas; Wang, Ena; Wells, Daniel K; Wyant, Timothy L; Cesano, Alessandra.
Afiliação
  • Rutella S; John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, Nottinghamshire, UK.
  • Cannarile MA; Centre for Health, Ageing and Understanding Disease (CHAUD), Nottingham Trent University, Nottingham, Nottinghamshire, UK.
  • Gnjatic S; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Penzberg, Germany.
  • Gomes B; Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Guinney J; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Basel, Switzerland.
  • Karanikas V; Sage Bionetworks, Seattle, Washington, USA.
  • Karkada M; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Zurich, Switzerland.
  • Kirkwood JM; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.
  • Kotlan B; Department of Medicine, Division of Hematology/ Oncology, University of Pittsburgh School of Medicine and Melanoma Center at UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
  • Masucci GV; National Institute of Oncology, Budapest, Hungary.
  • Meeusen E; Department Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Monette A; CancerProbe Pty Ltd, Prahran, Victoria, Australia.
  • Naing A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  • Thorsson V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tschernia N; Institute for Systems Biology, Seattle, Washington, USA.
  • Wang E; Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Wells DK; Allogene Therapeutics, South San Francisco, California, USA.
  • Wyant TL; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
  • Cesano A; Biolojic Design Inc, Cambridge, Massachusetts, USA.
J Immunother Cancer ; 8(2)2020 10.
Article em En | MEDLINE | ID: mdl-33127656
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Disseminação de Informação / Imunoterapia Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Disseminação de Informação / Imunoterapia Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido